輸入代號或公司名稱後按 Enter
4116

明基醫

-0.30 (-0.75%)最後更新 2026-09-11
台灣 · 上櫃 · 生技醫療業
39.606成交張數15.00本益比1.60股價淨值比5.05%殖利率2026-09-11資料日期

每股盈餘

柱為單季 EPS,線為近四季合計;近十年

季度單季 EPS年增近四季 EPS歸屬母公司淨利(億)淨利率ROE(季)ROE(近四季)
2026Q21.33504.5%2.640.594.1%5.49%10.91%
2026Q10.28-44.0%1.530.130.9%1.16%6.46%
2025Q40.41-30.5%1.750.191.4%1.68%6.95%
2025Q30.623.3%1.930.272.1%2.56%7.84%
2025Q20.22-66.1%1.910.100.7%0.92%8.02%
2025Q10.50-2.0%2.340.221.8%2.03%9.91%
2024Q40.59-28.9%2.350.262.0%2.37%9.44%
2024Q30.60-27.7%2.590.272.2%2.46%10.68%
2024Q20.6562.5%2.820.292.5%2.78%11.41%
2024Q10.510.0%2.570.232.1%2.13%10.60%
2023Q40.8362.7%2.570.373.1%3.41%9.97%
2023Q30.836.4%2.250.373.2%3.36%8.99%
2023Q20.40-48.7%2.200.182.4%1.57%8.60%
2023Q10.51-74.1%2.580.233.3%1.94%10.32%
2022Q40.5182.1%4.040.233.0%1.94%16.12%
2022Q30.78310.5%3.810.354.6%2.99%15.39%
2022Q20.781014.3%3.220.354.3%3.11%13.27%
2022Q11.971690.9%2.510.8814.2%8.18%10.32%
2021Q40.28-60.6%0.650.122.9%1.18%2.76%
2021Q30.19-40.6%1.080.082.2%0.82%4.72%
2021Q20.07-61.1%1.210.031.0%0.32%5.34%
2021Q10.11-38.9%1.320.051.5%0.46%5.58%
2020Q40.7134.0%1.390.327.7%3.05%5.90%
2020Q30.32-27.3%1.210.143.9%1.40%5.27%
2020Q20.18-30.8%1.330.082.6%0.81%5.89%
2020Q10.18-60.9%1.410.082.6%0.75%5.95%
2019Q40.53-17.2%1.690.246.6%2.27%7.23%
2019Q30.4415.8%1.800.205.6%1.92%7.89%
2019Q20.26-27.8%1.740.123.5%1.15%7.74%
2019Q10.46283.3%1.840.206.1%1.94%7.88%
2018Q40.6468.4%1.500.288.2%2.78%6.49%
2018Q30.3852.0%1.240.175.4%1.67%5.51%
2018Q20.3628.6%1.110.165.2%1.62%4.98%
2018Q10.12-14.3%1.030.052.0%0.50%4.50%
2017Q40.3815.2%1.050.176.4%1.70%4.63%
2017Q30.2525.0%1.000.113.6%1.08%4.45%
2017Q20.28-3.5%0.950.134.9%1.26%4.29%
2017Q10.14-39.1%0.960.062.9%0.63%4.19%
2016Q40.331.050.156.8%1.47%
2016Q30.200.094.0%0.89%